Status:
TERMINATED
Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Idiopathic Membranous Nephropathy
Eligibility:
All Genders
18+ years
Brief Summary
Idiopathic membranous nephropathy (IMN) remains a common cause of the nephrotic syndrome in adults and one of the leading known causes of end-stage renal disease. Identification of circulating autoant...
Eligibility Criteria
Inclusion
- (1) Patients who provided informed consent
- (2) Patients who are diagnosed as membranous nephropathy by renal biopsy
- (3) 18 years of age or older, male or female
Exclusion
- (1) identification of Secondary factors such as infectious diseases, rheumatic diseases, tumors, drugs and so on
- (2) Previous medicine history of immunosuppressive medication and corticosteroids
- (3) Patients who are not expected to complete 6 months of follow-up
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 10 2020
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT03475602
Start Date
March 1 2018
End Date
May 10 2020
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nephrology Dept,Guangdong General Hospital
Guangzhou, Guangdong, China